Custodiol-N
Sponsors
Dr. Franz Koehler Chemie GmbH, Dr. F. Köhler Chemie GmbH
Conditions
Aortic Valve DiseaseCoronary Artery Disease (CAD)Heart FailureHeart TransplantationLiver transplantationcongenital heart malformation inchildrenheart transplantation in childrenliver or kidney-pancreatic
transplantation
Phase 2
Phase III Study Comparing Two Methods of Cardioplegia in Coronary Artery Bypass Surgery
CompletedNCT01444235
Start: 2011-03-31End: 2012-07-31Updated: 2013-05-17
Study of Organ Perfusion in Heart Transplantation in Children
RecruitingNCT06032195
Start: 2023-08-15End: 2027-09-01Target: 15Updated: 2026-01-30
A prospective randomized single blind multicenter phase II study of organ perfusion with Custodiol-N compared with Custodiol in heart transplantation in children (CL-N-HTX-Paed-II/10/20)
RecruitingCTIS2023-510492-57-00
Start: 2025-03-05Target: 15Updated: 2025-12-04
A prospective randomized, single-blind, multicenter phase II study comparing two methods of cardioplegia in cardiac surgery due to congenital heart malformation in children:
Custodiol-N versus Custodiol (CL-N-CP-Paed-II/09/19)
SuspendedCTIS2024-511517-38-00
Start: 2024-11-05Target: 100Updated: 2025-03-28
Phase 3
Phase III Study Comparing Two Methods of Cardioplegia in Aortic Valve Surgery Custodiol-N Versus Custodiol
CompletedNCT02098772
Start: 2014-05-31End: 2018-12-31Updated: 2020-01-18
Study of Organ Perfusion With Custodiol-N Solution Compared With Custodiol Solution in Heart Transplantation
CompletedNCT02869022
Start: 2016-07-31End: 2019-09-02Updated: 2020-01-18
A prospective, randomized, single blind, multicentre phase III study on organ preservation with Custodiol-N solution compared with Custodiol solution in or-gan transplantation (kidney, liver and pancreas)
RecruitingCTIS2024-512444-29-00
Start: 2019-05-07Target: 362Updated: 2025-12-09
A Prospective, randomized, single blind, multicenter Phase III study on organ preservation with Custodiol-N solution compared with Custodiol solution in liver transplantation
Not yet recruitingCTIS2024-518174-13-00
Target: 200Updated: 2025-12-22